Crop Life Science Limited (NSE:CLSL)
India · Delayed Price · Currency is INR 66.50
+0.50 (0.76%)
Jul 31, 2026, 3:14 PM IST
Crop Life Science Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 66.35 | 58.92 | 60.23 | 40.71 | 28.14 |
Depreciation & Amortization | 49.42 | 48.26 | 44.22 | 37.05 | 21.27 |
Other Amortization | - | - | - | - | 1.24 |
Loss (Gain) From Sale of Assets | -0.63 | 0.01 | -5.03 | - | -0.4 |
Provision & Write-off of Bad Debts | 1.44 | -1.06 | 6.96 | -2.47 | 2.39 |
Other Operating Activities | 51.47 | 41.12 | 7.16 | 25.15 | 19.97 |
Change in Accounts Receivable | -54.91 | 82.14 | -455.09 | 45.54 | -110.17 |
Change in Inventory | -216.62 | -90.76 | -136.3 | -39.26 | 71.08 |
Change in Accounts Payable | 85.24 | -113.01 | 326.39 | -22.4 | 23 |
Change in Other Net Operating Assets | -58.08 | -46.61 | 68.14 | -61.58 | -57.97 |
Operating Cash Flow | -76.31 | -20.99 | -83.32 | 22.75 | -1.45 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -19.23 | -39.03 | -74.4 | -50.16 | -43.68 |
Sale of Property, Plant & Equipment | 53.84 | 0.23 | 26.58 | - | 23.71 |
Investment in Securities | -0.38 | - | - | - | - |
Other Investing Activities | -18.46 | 3.75 | 13.6 | 5.32 | 0.09 |
Investing Cash Flow | 15.77 | -35.04 | -34.22 | -44.84 | -19.88 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 307.46 | 100.44 | 61.31 | - | 44.18 |
Long-Term Debt Issued | - | - | - | 58.51 | - |
Total Debt Issued | 307.46 | 100.44 | 61.31 | 58.51 | 44.18 |
Short-Term Debt Repaid | - | - | - | -7.66 | - |
Long-Term Debt Repaid | -33.68 | -11.32 | -134.68 | -12.89 | -12.35 |
Total Debt Repaid | -33.68 | -11.32 | -134.68 | -20.55 | -12.35 |
Net Debt Issued (Repaid) | 273.78 | 89.12 | -73.38 | 37.95 | 31.83 |
Issuance of Common Stock | - | - | 251.06 | - | - |
Other Financing Activities | -54.36 | -47.53 | -43.42 | -32.75 | -20.7 |
Financing Cash Flow | 219.42 | 41.59 | 134.27 | 5.2 | 11.12 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 158.87 | -14.44 | 16.73 | -16.89 | -10.21 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -95.54 | -60.02 | -157.73 | -27.42 | -45.13 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -4.61% | -2.99% | -7.94% | -2.09% | -4.42% |
Free Cash Flow Per Share | -5.46 | -3.50 | -9.20 | -2.29 | -3.76 |
Levered Free Cash Flow | -166.76 | -109.05 | -180.82 | -61.97 | -70.85 |
Unlevered Free Cash Flow | -132.79 | -81.63 | -162.67 | -42.78 | -58.64 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 54.36 | 47.53 | 46.65 | 32.75 | 0.7 |
Cash Income Tax Paid | 26.97 | 21.7 | 21.4 | 17.52 | 10.17 |
Change in Working Capital | -244.36 | -168.25 | -196.86 | -77.7 | -74.07 |